Page last updated: 2024-10-24

cefuroxime and Communicable Diseases

cefuroxime has been researched along with Communicable Diseases in 2 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kahan, NR1
Chinitz, DP1
Waitman, DA1
Kahan, E1
Vuori-Holopainen, E1
Peltola, H1
Kallio, MJ1

Trials

1 trial available for cefuroxime and Communicable Diseases

ArticleYear
Narrow- versus broad-spectrum parenteral anatimicrobials against common infections of childhood: a prospective and randomised comparison between penicillin and cefuroxime.
    European journal of pediatrics, 2000, Volume: 159, Issue:12

    Topics: Adolescent; Cefuroxime; Cephalosporins; Child; Child, Preschool; Communicable Diseases; Female; Huma

2000

Other Studies

1 other study available for cefuroxime and Communicable Diseases

ArticleYear
When gatekeepers meet the sentinel: the impact of a prior authorization requirement for cefuroxime on the prescribing behaviour of community-based physicians.
    British journal of clinical pharmacology, 2006, Volume: 61, Issue:3

    Topics: Administration, Oral; Anti-Bacterial Agents; Cefuroxime; Communicable Diseases; Drug Prescriptions;

2006